SEC 13F Intelligence

Managers / Q3 2019 · view latest →

SYQUANT CAPITAL SAS

CIK 0001766392 · 25 AVENUE KLEBER, PARIS, I0, 75116 · 0033142569307

Reported Value
$365M
Q3 2019
Positions
17
Filings on Record
32
2019–present window
Filed
Oct 17, 2019
original filing

Summary

Syquant Capital Sas reported $365M in U.S.-listed holdings across 17 positions for Q3 2019.

The portfolio is heavily concentrated: Medidata Solutions alone accounts for 38.9% of reported value.

Compared with Q2 2019, the fund opened 14 new positions and exited 11.

Portfolio Metrics

Turnover
+71.9%
vs prior filed quarter
Top-10 Concentration
+97.9%
share of reported value
Largest Position
+38.9%
Medidata Solutions
New / Exited
14 / 11
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $117MQ4 ’18Q1 ’19: $258MQ2 ’19: $312MQ3 ’19: $365MQ4 ’19: $194MQ4 ’19Q1 ’20: $407MQ2 ’20: $215MQ3 ’20: $196MQ4 ’20: $387MQ4 ’20Q1 ’21: $386MQ2 ’21: $83MQ3 ’21: $164MQ4 ’21: $262MQ4 ’21Q1 ’22: $195MQ2 ’22: $90MQ3 ’22: $165MQ4 ’22: $41MQ4 ’22Q1 ’23: $43MQ2 ’23: $138MQ3 ’23: $255MQ4 ’23: $22MQ4 ’23Q1 ’24: $64MQ2 ’24: $10MQ3 ’24: $27MQ4 ’24: $70MQ4 ’24Q1 ’25: $141MQ2 ’25: $302MQ3 ’25: $348MQ4 ’25: $817MQ4 ’25Q1 ’26: $640MQ2 ’26: $447Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 78.1%Other: 16.0%Closed-End Fund: 5.2%ADR: 0.6%
  • Common Stock · 78.1% · $285M
  • Other · 16.0% · $59M
  • Closed-End Fund · 5.2% · $19M
  • ADR · 0.6% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
BROOKFIELD ASSET MGMT INCNEW+1.10M1.10M+$58M$58M
GENESEE & WYO INCNEW+458.6K458.6K+$51M$51M
ALTABA INCNEW+981.1K981.1K+$19M$19M
MONOTYPE IMAGING SOLUTIONSNEW+384.3K384.3K+$8M$8M
INTUINTUITNEW+21.6K21.6K+$6M$6M
CLXCLOROX CO DELNEW+37.4K37.4K+$6M$6M
OMNOVA SOLUTIONS INCNEW+426.3K426.3K+$4M$4M
WESCO AIRCRAFT HLDGS INCNEW+256.8K256.8K+$3M$3M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

17 positions
#IssuerClass% PortfolioValueShares
1MEDIDATA SOLUTIONS INCCOM38.85%$142M1.55M
2CELGCELGENE CORPhistory →COM16.85%$62M619.7K
3BROOKFIELD ASSET MGMT INCCOM15.93%$58M1.10M
4GENESEE & WYO INCCL A13.88%$51M458.6K
5ALTABA INCCOM5.23%$19M981.1K
6MONOTYPE IMAGING SOLUTIONSCOM2.08%$8M384.3K
7INTUINTUIThistory →COM1.57%$6M21.6K
8CLXCLOROX CO DELhistory →COM1.56%$6M37.4K
9OMNOVA SOLUTIONS INCCOM1.18%$4M426.3K
10WESCO AIRCRAFT HLDGS INCCOM0.77%$3M256.8K
11CTRIP COM INTL LTDSPONSORED ADS0.64%$2M80.0K
12SPARK THERAPEUTICS INCCOM0.55%$2M20.6K
13CASTLE BRANDS INCCOM0.49%$2M1.41M
14CORINDUS VASCULAR ROBOTICS ICOM0.13%$487,000113.7K
15DRYSHIPS INCCOM0.12%$441,00084.3K
16TERRAFORM PWR INCCOM CL A0.09%$313,00017.2K
17MCRNMILACRON HLDGS CORPCOM0.08%$287,00017.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2026$447M38Jul 9, 202613F-HRchanges · EDGAR ↗
Q1 2026$640M40Apr 10, 202613F-HRchanges · EDGAR ↗
Q4 2025$817M37Jan 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$348M17Oct 28, 202513F-HRchanges · EDGAR ↗
Q2 2025$302M14Jul 18, 2025RESTATEMENTchanges · EDGAR ↗
Q1 2025$141M14Apr 23, 202513F-HRchanges · EDGAR ↗
Q4 2024$70M6Jan 13, 202513F-HRchanges · EDGAR ↗
Q3 2024$27M5Oct 4, 202413F-HRchanges · EDGAR ↗
Q2 2024$10M5Jul 10, 202413F-HRchanges · EDGAR ↗
Q1 2024$64M6Apr 9, 202413F-HRchanges · EDGAR ↗
Q4 2023$22M7Jan 10, 202413F-HRchanges · EDGAR ↗
Q3 2023$255M9Oct 12, 202313F-HRchanges · EDGAR ↗
Q2 2023$138M11Jul 10, 202313F-HRchanges · EDGAR ↗
Q1 2023$43M7Apr 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$41M14Jan 17, 202313F-HRchanges · EDGAR ↗
Q3 2022$165M25Oct 11, 202213F-HRchanges · EDGAR ↗
Q2 2022$90M32Jul 8, 202213F-HRchanges · EDGAR ↗
Q1 2022$195M35Apr 7, 202213F-HRchanges · EDGAR ↗
Q4 2021$262M43Jan 12, 202213F-HRchanges · EDGAR ↗
Q3 2021$164M42Oct 14, 202113F-HRchanges · EDGAR ↗
Q2 2021$83M41Jul 14, 202113F-HRchanges · EDGAR ↗
Q1 2021$386M53Apr 20, 202113F-HRchanges · EDGAR ↗
Q4 2020$387M81Feb 5, 202113F-HRchanges · EDGAR ↗
Q3 2020$196M62Oct 21, 202013F-HRchanges · EDGAR ↗
Q2 2020$215M23Aug 5, 202013F-HRchanges · EDGAR ↗
Q1 2020$407M18Apr 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$194M16Jan 8, 202013F-HRchanges · EDGAR ↗
Q3 2019$365M17Oct 17, 201913F-HRchanges · EDGAR ↗
Q2 2019$312M14Jul 5, 201913F-HRchanges · EDGAR ↗
Q1 2019$258M15Apr 12, 201913F-HRchanges · EDGAR ↗
Q4 2018$117M11Feb 4, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.